Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke

Summary

The clinical study with UMC119-06 is designed to investigate the safety in patients with acute ischemic stroke ("AIS"). This will be a dose escalation, open-label, single-center study in adult with acute ischemic stroke. UMC119-06 is ex vivo cultured human umbilical cord tissue-derived mensenchymal stem cells product which is intended for treatment of acute ischemic stroke.

Timeline

Start

2019-12-05

Primary completion

2023-12-31

Completion

2025-12-31

Drugs

Indications